Lisata Therapeutics Announces Participation in Upcoming Conferences in November 2022
BASKING RIDGE, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq:LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that management will participate in the following events:
Related news for (LSTA)
- Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development
- Lisata Therapeutics to Present at the 2025 BIO International Convention
- Lisata Therapeutics Announces Research License with Catalent
- Lisata Therapeutics to Present at the Investival Showcase USA
- Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development